RRAD Antikörper (Middle Region)
Kurzübersicht für RRAD Antikörper (Middle Region) (ABIN634370)
Target
Alle RRAD Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- RRAD antibody was raised against the middle region of RRAD
-
Aufreinigung
- Affinity purified
-
Immunogen
- RRAD antibody was raised using the middle region of RRAD corresponding to a region with amino acids LARIFGGVEDGPEAEAAGHTYDRSIVVDGEEASLMVYDIWEQDGGRWLPG
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
RRAD Blocking Peptide, (ABIN940179), is also available for use as a blocking control in assays to test for specificity of this RRAD antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of RRAD antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- RRAD (Ras-Related Associated with Diabetes (RRAD))
-
Andere Bezeichnung
- RRAD
-
Hintergrund
- RRAD may play an important role in cardiac antiarrhythmia via the strong suppression of voltage-gated L-type Ca2+ currents.
-
Molekulargewicht
- 33 kDa (MW of target protein)
Target
-